Palbociclib: prices and alternatives
Palbociclib is a CDK4/6 inhibitor indicated for adults with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer, in combination with an aromatase inhibitor as initial endocrine-based therapy or with fulvestrant following disease progression on prior endocrine therapy. It is also…
4 products with this active ingredient from 2 manufacturers. Official prices from 27786 to 62136 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.



